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Abstract
Background: While evidence on the cost of mental illness is growing, little is known about the
cost-effectiveness of programmes in the areas of mental health promotion (MHP) and mental
disorder prevention (MDP). The paper aims at identifying and assessing economic evaluations in
both these areas to support evidence based prioritisation of resource allocation.
Methods:  A systematic review of health and non health related bibliographic databases,
complemented by a hand search of key journals and analysis of grey literature has been carried out.
Study characteristics and results were qualitatively summarised. Economic evaluations of
programmes that address mental health outcome parameters directly, those that address relevant
risk factors of mental illness, as well as suicide prevention interventions were included, while
evaluations of drug therapies were excluded.
Results:  14 studies fulfilled the inclusion criteria. They varied in terms of topic addressed,
intervention used and study quality. Robust evidence on cost-effectiveness is still limited to a very
small number of interventions with restricted scope for generalisability and transferability. The
most favourable results are related to early childhood development programmes.
Conclusion: Prioritisation between MHP and MDP interventions requires more country and
population-specific economic evaluations. There is also scope to retrospectively add economic
analyses to existing effectiveness studies. The nature of promotion and prevention suggests that
innovative approaches to economic evaluation that augment this with information on the challenges
of implementation and uptake of interventions need further development.
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Background
Increasing evidence about the high social and economic
costs of poor mental health has contributed to a growing
recognition of the need to promote positive mental health
and wellbeing, as well as to prevent the onset of mental ill-
ness [1-3]. This is supported by data showing that promo-
tion and prevention strategies reduce the individual and
social impacts of poor mental health [4]. Thus, these inter-
ventions may not only be effective but potentially cost-
effective in an economic sense.
One in four individuals can expect to experience mental
health problems during their lifetimes [5]. Conservatively
the costs of poor mental health have been estimated to
account for between 3% and 4% of GDP in developed
countries [6]. A number of long term longitudinal studies
indicate that untreated mental health and behavioural
problems in childhood, in particular, can have profound
longstanding social and economic consequences in adult-
hood, including increased contact with the criminal jus-
tice system, reduced levels of employment and often
lower salaries when employed, and personal relationship
difficulties [7-10]. Yet there is a growing body of literature
that provides some (typically short term) evidence on the
effectiveness of a range of prevention programmes which
address known or at least assumed risk factors for mental
disorders [11-20]. There is also some evidence on the
effectiveness of programmes focussing on the early detec-
tion and early intervention for severe mental disorders,
particularly depression and schizophrenia [21-24].
In the context of increasing budget constraints and rising
demands for evidence-based health spending, evidence
on effectiveness alone is insufficient for policy making; in
addition to knowing what works and in what context,
information on the economic costs and consequences of
any intervention is required. Given the inevitable con-
straints on funds available for all public sector interven-
tions, economic evaluations are increasingly used as one
key input to decisions on how to allocate resources to var-
ious health system actions, most notably for assessing
pharmaceuticals, medical devices and procedures [25].
More recently, arguments have also been put forward to
examine the economic case of all areas of public health
and health promotion [26] and while some studies have
been conducted in these areas, such evaluations remain
few compared with health care interventions [27].
It is therefore no surprise that the use of economic evalu-
ations in the field of mental health care generally contin-
ues to grow [28], but little has previously been reported
on the extent to which the cost-effectiveness of mental
health promotion (MHP) and mental disorder prevention
(MDP) programmes has been considered and, if so, what
form these evaluations take. This paper aims to systemat-
ically collate relevant evidence to help address the ques-
tion as to whether it is worth investing in MHP and MDP
interventions from an economic perspective. It seeks to
identify those areas in which economic evaluations have
most commonly been used, and reports on the economic
techniques used. It also looks at the extent to which avail-
able economic studies focus solely on the prevention of
mental health disorders or also have sought to assess the
cost effectiveness of the promotion of improved mental
well-being.
Methods
A systematic review protocol was developed in line with
recommended guidelines [29-31] in order to identify eco-
nomic evaluations in the areas of MDP and MHP. A range
of bibliographic databases, MEDLINE/PUBMED, Embase,
Cinahl, Psychinfo, Psyndex, Econlit, ERIC and NHS EED
were included in the protocol. This was complemented by
a hand search of key journals, as well as an internet search
for grey literature, including governmental reports and
academic working papers. Precise search terms were
dependent on the database used, but all included core
medical subject headings and title/abstract phrases
including 'mental disorder', 'mental illness', '(primary)
prevention', 'health promotion', 'preventive measures',
'occupational health', 'workplace health promotion' and
'suicide prevention'. In addition to the use of the Medical
Subject Heading 'costs and cost analysis', other economic
terms used were 'economics', 'cost effectiveness', 'cost util-
ity', 'cost benefit', 'cost consequences' and 'economic eval-
uation'.
Considering the fragmented pattern of scientific evidence
in the MHP and MDP fields a pragmatic approach to
defining inclusion and exclusion criteria was required.
Firstly, those economic evaluations of mental health pro-
motion or prevention interventions were included that
addressed either mental well-being or mental disorder as
an outcome parameter directly (e.g. changes in a measure
of happiness or a depression scale). Secondly, studies
which focused on preventing outcomes specifically recog-
nised as well-known risk factors for future mental disorder
were included (e.g. behavioural problems in children).
Additionally, we included papers on suicide prevention,
although suicide is not always related to mental health
problems.
While the definition of mental disorders was based on the
ICD classification, studies which evaluated programmes
on alcohol and drug dependency were excluded. In
respect of prevention we restricted the review to studies on
primary and secondary prevention alone as defined by the
WHO [32]. Thus, we included evaluations of early detec-
tion to lower the rate of established cases of mental disor-
ders, while tertiary prevention which would include muchBMC Public Health 2008, 8:20 http://www.biomedcentral.com/1471-2458/8/20
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use of drug therapy was excluded. Furthermore, with
respect to economic evaluation, we took into account
methodological discussions which suggest that for public
health interventions the definition of economic evalua-
tion must be broadened so as to include methods such as
econometric studies of regulatory, fiscal or legislative
change. In addition, we wanted to ensure that studies
which combined qualitative evidence on impact, such as
individual satisfaction rates, alongside economic data
would be included in our review [33]. Thus, the review
protocol design went beyond conventional economic
evaluations to identify other relevant economic analyses,
including cost consequence analysis where costs and
effectiveness measures are not synthesised into a single
ratio. However, studies that only addressed costs such as
cost-of-illness studies were excluded.
There were no date restrictions imposed on the biblio-
graphic database search, but our analysis was limited to
studies in English and German. Study selection was ini-
tially on the basis of study abstract, with data extraction
and assessment conducted independently by two review-
ers based on available checklists [25,34]. According to
suggested methodological standards [35] quantitative
results in monetary terms were converted into the single
currencies of US$ and Euros by using GDP Purchasing-
Power-Parities. Additionally, they were adjusted for price
levels referring to the year 2006.
Results
This search process resulted in 398 hits. 361 papers were
excluded on the basis of abstract alone. From the 37
remaining studies, 5 could not be obtained, leaving 32
studies, 18 of which did not meet all inclusion criteria,
leaving 14 studies in our analysis (see Figure 1; for a full
reference list of excluded studies see appendix).
Compared to the economic evaluation of medical inter-
ventions for mental illness (e.g. pharmaceuticals), the
number of available studies that evaluate MHP or MDP
interventions from an economic perspective is low. The
broad and fragmented nature of promotion and preven-
tion interventions meant that our hand and internet
search were however able to identify 8 of the 14 studies,
as they did not appear in the largely medical databases.
Table 1 provides a summary of the study characteristics
and main results.
Half of these studies evaluated programmes in three Euro-
pean countries (the UK, Netherlands and Sweden) with
the remainder being in the US. Some of these US based
evaluations, in fact covered a number of programmes
[36,37]. One made use of effectiveness results from a vast
number of different US early childhood development
(ECD) interventions and adolescent support programmes
[37]. In terms of (effectiveness) evaluation activity, com-
mon with many health promoting or public health inter-
ventions, this seemed to be higher in the USA than in
Europe (at least in the field of ECD). The majority of eco-
nomic evaluations applied conventional economic tech-
niques such as cost benefit, cost effectiveness, cost utility
or cost consequence analysis. Some studies included sim-
ulation models in order to look at projected long term
costs and benefits.
While six studies were conducted prospectively alongside
the collection of primary data [38-43], eight economic
evaluations were either based on the retrospective second-
ary analysis of data resulting from experimental or quasi-
experimental studies [44-46], or developed simulation
models using effectiveness data obtained through system-
atic and non-systematic reviews [36,37,47-49]. Although
in the majority of studies the study design for measuring
effectiveness was based on randomly selected interven-
tion and control groups, due to the nature of these inter-
ventions double-blinding was not possible. As in any
other case of preventive intervention evaluations, this
raises the potential of bias in outcome measurement.
Moreover, in some cases the study design was a controlled
observational trial where the intervention group was com-
pared to a non-randomised control group. This again is
sub-optimal with respect to evaluating the causal relation-
ships between an intervention and outcomes (see table 1).
While the evaluations identified were diverse in terms of
type of intervention, a high proportion of the studies dealt
with measures to prevent depression, sometimes with a
secondary objective of preventing suicide. The remainder
focused on addressing some of the overall risk factors for
mental disorders. No economic evaluations were found of
interventions that address mental well-being rather than
mental illness as an outcome parameter. In the following
section, the main characteristics of studies are briefly pre-
sented.
Flow diagram of study selection process Figure 1
Flow diagram of study selection process.
Full-text articles included 
(n=14) 
Excluded references 
(n=361) 
Full text not available 
(n=5) 
Excluded references (n=18): 
No full economic evaluation: n= 10 
Prevention of alcohol dependency: n= 4 
Too general/no focus on MHP/MDP: n= 2 
(Drug )therapy: n= 2 
Full-text articles retrieved  
(n=32) 
Potentially relevant 
references identified (n= 398)BMC Public Health 2008, 8:20 http://www.biomedcentral.com/1471-2458/8/20
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Table 1: Study characteristics and results
Source Evaluation 
type
Country Intervention Source 
effectiveness data
Type of 
data
Time 
horizon
Results*
Programmes to prevent depression/sucide
Smit et al. (2006) 
[38]
CEA Nether-
lands
Minimal contact-therapy 
for primary prevention of 
depression
Pragmatic RCT Primary 
data
1 yr 80% probability of cost-
effectiveness if WTP per 
case avoided is below 
US$ 23,000
Petrou et al. 
(2006) [39]
CEA UK Home visiting therapist f. 
primary prevention of 
post-natal depression
Pragmatic RCT Primary 
data
18 months 70% probability of cost-
effectiveness if WTP per 
depressive month 
avoided is below US$ 
1,800
Lynch et al. 
(2006) [46]
CEA USA CBT for high at risk 
teens for depression
RCT Secondary 
data
1 yr US$ -14 to US$ 24 per 
DFD; US$ -12,200 to 
US$ 3,400 per QALY
Valenstein et al. 
(2001) [47]
CUA USA Various types of 
Screening for depression
Secondary literat./
not specified; Meta-
analysis of RCTs
Simulation/
modelling
Life-time Cost utility ratios 
unfavourable; 1-time 
screening compared to 
no screening lowest 
ICUR(on average US$ 
47,000 per QALY)
Sari et al. (2007) 
[49]
CBA USA General education and 
peer support to prevent 
suicide in high-school
Secondary literature/
not specified
Simulation/
modelling
1 yr Net benefit: US$ 21 
million and US$ 32 
million respectively; 
ratio: US$ 2.36:1 and 
US$ 4.3:1
Zaloshnja et al. 
(2003) [44]
CUA/CBA USA Lay people training for 
crisis-support
Prospective 
observational trial
Secondary 
data
10 yrs Benefit-cost ratio: 47:1; 
ICUR: US$ 460 per 
QALY
Appleby et al. 
(2000) [42]
CEA UK Education for health 
professionals to assess 
and manage suicidal 
patients
Prospective 
observational trial
Primary 
data
1 yr US$ 6,200 per LYG; US$ 
183,000 per suicide 
prevented
Byford et al. 
(1999) [41]
CCA UK Social work intervention 
for adolescents with risk 
for self-harm
Pragmatic RCT Primary 
data
5 months Intervention not more 
effective and not more 
costly
Rutz et al. (1992) 
[45]
CBA Sweden Educational programme 
for GPs to detect 
depression
Prospective 
observational trial
Secondary 
data
Life-time Net benefit: US$ 37 
million
Programmes that address overall risk factors for mental disorders
Wiggins et al. 
(2004) [40]
CCA UK Post-natal support for 
young mothers in 
deprived city areas
Pragmatic RCT Primary 
data
18 months Interventions not more 
effective and not cost 
saving
McAuley et al. 
(2004) [43]
CEA, CCA UK Home start support for 
young families
Prospective 
observational trial
Primary 
data
11 months Intervention not more 
effective and more 
costly
Schweinhart 
(2005) [48]
CBA USA Early child development 
programme (ECD)
Pragmatic RCT Simulation/
modelling
40 yrs US $ 19.81 return per 
invested US$
Lynch (2004) 
[36]
CBA USA ECD Several pragmatic 
RCTs
Simulation/
modelling
45 yrs After 17 yrs: budget 
benefits outweigh costs; 
benefit-cost ratios: US$ 
4.01 to 9.27 per $ 
invested
Aos et al. (2004) 
[37]
CBA USA Several type of childhood 
and adolescent support 
programmes
Systematic review of 
RCTs
Simulation/
modelling
Life-time From net-benefit of US$ 
33,100 to net costs of 
US$ 52,000 depending 
on programme
CBA: Cost benefit analysis; CCA: cost-consequence analysis; CEA: Cost effectiveness analysis; CUA: Cost utility analysis; DFD: depression free day; 
ICUR: Incremental cost utility ratio; LYG: Life year gained; QALY: quality adjusted life years; RCT: Randomised controlled trial; WTP: willingness to pay; 
* original results have been converted into US$ according to GDP-PPP where required and inflated to 2006 price levelsBMC Public Health 2008, 8:20 http://www.biomedcentral.com/1471-2458/8/20
Page 5 of 11
(page number not for citation purposes)
Programmes to prevent depression or suicide
Smit et al. (2006) [38] in the Netherlands evaluated the
cost-effectiveness of minimal-contact psychotherapy as a
preventive measure for individuals at high risk of depres-
sion. At 12 months the incidence rate ratio of depression
was 0.65 when comparing the intervention (11.9) and
usual care groups (18.3). At a cost-effectiveness threshold
of US$ 23,000 (€ 20,000) per case avoided, a 70% to 80
% probability (depending on the costs included) that the
intervention would be cost-effective compared to stand-
ard actions was shown. Additionally, there was a 40% to
60% probability that the intervention would be dominant
compared to standard care (i.e. better outcome at a lower
cost). However, these calculations are based on a rather
short time-horizon of one year and the trial design does
not guarantee an unbiased evaluation. As the authors
remark, the results cannot be reliably transferred to other
countries because of the differing health care system con-
texts.
In England, Petrou et al. (2006) [39] evaluated a preven-
tive intervention targeted at women who were at high risk
of developing postnatal depression. Based on a pragmatic
randomised controlled trial they found a non-significant
increase in depression-free-months, as well as a non-sig-
nificant increase in health and social care costs in the
intervention group. At a willingness to pay threshold of
US$ 1,800 (€ 1,500) per prevented month of depression,
the probability that the intervention is cost-effective was
reported to be 70%. The non-significant nature of effec-
tiveness data meant that this probability did not exceed
80% even at substantially higher willingness to pay
thresholds.
Lynch et al. (2005) [46] evaluated the cost effectiveness of
cognitive-behaviour therapy for high-risk teenagers with
depressive parents over a one year period. In the year after
the intervention, intervention participants reported signif-
icantly more depression free days than the control group
(301 versus 248). The authors argued in favour of the
intervention based on the fact that cost-effectiveness
ratios are within the same range as those for accepted
depression treatments in the US, with the reported cost
per quality adjusted life year (QALY) remaining below the
threshold of US $ 50,000 (€ 45,000) per QALY gained.
However, the long-term effects of the intervention were
not analysed and the intervention group was rather small
which does not allow the results to be generalised.
Valenstein et al. (2001) [47] evaluated alternative strate-
gies of screening for depression among adults in the US.
They assumed that screening would increase the diagnosis
of depression by 50 % for individuals with major depres-
sion (from 45 % to 68 %). Treatment effects of diagnosed
depression were then based on a meta-analysis of rand-
omized controlled trials. Compared with no screening,
periodic or annual screening of 40-years old adults
resulted in rather unfavourable cost-utility ratios (US$
68,000/€ 60,000 to US $ 260,600/€ 220,000 per QALY).
The most favourable ratios (US$ 34,000/€ 30,000 to US $
60,000/€ 44,000 per QALY) were found with one-time
screening compared to no screening, yet the results were
not very robust in sensitivity analysis. According to the
authors, the cost-effectiveness of screening is likely to
improve if more effective treatment is available.
Five studies looked at the economic case for suicide pre-
vention: Sari et al. (2007) [49] analysed the net benefit of
two programmes, general suicide awareness versus peer
support programmes for the prevention of suicides in uni-
versity students in Florida. They applied a simulation
model using data on recorded suicides and a meta-analy-
sis to estimate the effectiveness of the two prevention pro-
grammes. Based on the estimated effect rates for general
education and peer support programmes to prevent sui-
cide (57 % and 60 % respectively), the authors came to
the conclusion that implementing both programmes in
all universities in Florida would result in net benefits of
US$ 21 million (€ 18 million) and US$ 32 million (€ 27
million) respectively, representing benefit-cost ratios of
US$ 2.36:1 and US$ 4.30:1 (€ 2:1 and € 3.70:1).
Zaloshnja et al. (2003) [44] retrospectively examined the
cost-effectiveness of a suicide prevention programme for
adolescent Native Americans belonging to the Western
Athabaskan tribe in rural New Mexico. A wide range of
interventions were included in the programme including
the use of lay people trained as 'natural helpers' to support
young people in crisis and notify mental health profes-
sionals of the need for assistance. The programme was
evaluated by a mirror study comparing the suicide rate of
the targeted age group before and after the intervention.
The suicide rate of other age groups was used as a 'quasi'
control group. Economic evaluation was conducted by
means of cost benefit and cost utility analysis. Results of
the former indicated a cost-benefit ratio of US$ 47 (€ 40)
per $ invested while the latter revealed a very favourable
incremental cost effectiveness ratio of US$ 460 (€ 514)
per QALY gained. The study is however limited by the lack
of an appropriate control group and the fact that it was
impossible to attribute any change in the suicide rate to a
specific element of the programme. The very specific set-
ting and population group for this study also implies that
its results cannot be generalised easily to other contexts or
settings.
Appleby et al. (2000) [42] analysed the costs and effects of
an educational intervention aimed at front-line health
professionals enabling them to assess and manage sui-
cidal patients. Based on effectiveness data (which indi-BMC Public Health 2008, 8:20 http://www.biomedcentral.com/1471-2458/8/20
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cated high rates of programme uptake, improvement of
assessment skills, as well as satisfaction with the training)
they estimated cost effectiveness ratios, using different
assumptions about the potential reduction in suicide rates
as result of this educational intervention. They estimated
that if 2.5 % of the suicides in a defined English district
could be prevented by the programme, then the cost per
life year gained (LYG) would be US$ 6,200 (€ 5,300) or
US$ 183,000 (€ 156,200) per suicide prevented. The
main limitations of the study however are that it is not
based on an experimental study design and moreover that
the reduction of suicide rates related to the use educa-
tional programme must be based on assumptions.
Byford et al. (1999) [41] in England analysed the cost-
effectiveness of a home-based social work intervention for
children and adolescents that had deliberately poisoned
themselves. The programme aimed at reducing suicidal
ideation and costs from further service demand. The study
found no statistically significant differences between
intervention and non-intervention group in terms of out-
come and total costs (although the intervention group
had higher intervention costs this was offset by lower
costs for subsequent health and social care service utilisa-
tion). According to the authors, the intervention could be
considered as cost-effective as routine care alone.
Rutz et al. (1992) [45] conducted a partial cost-benefit
analysis where they compared a Swedish educational pro-
gramme for general practitioners which aimed at prevent-
ing suicide via improved treatment of depression with no
such intervention. As a proxy to calculating monetary ben-
efits they used suicides prevented. The related numbers of
reduced days of sick leave (10,898 days) and lives saved
(19), as well as reduced drug costs, resulted in an average
net benefit of US$ 37 million (€ 31.6 million). However
the results were sensitive to the method of calculating
monetary benefits and assumptions concerning suicides
avoided. Furthermore, the analysis is limited as effective-
ness data on the educational programme for suicide
reduction were not derived from a rigorous experimental
study design but from quasi-randomisation with retro-
spective comparison of two Swedish regions with and
without the programme. The long term impacts of the
training intervention on physician practice also remain
unclear. Thus, whether any reduction in suicide can be
causally related to the educational programme remains
ambiguous.
Programmes that address overall risk factors
A further group of studies evaluated interventions that
were targeted at young parents or mothers having to deal
with stressful socio-economic circumstances. Two pro-
grammes to support mothers in deprived London inner-
city areas have been compared to standard care in terms of
maternal and child health (including mental health) and
costs by Wiggins et al. (2004) [40]. Both interventions
were more costly than standard services and did not show
any significant impact on primary outcomes. This is simi-
lar to a study by McAuley et al. (2004) [43] which evalu-
ated the outcomes and costs of 'home-start support for
young families under stress' in Northern Ireland and
southern England. Again, no significant improvements in
outcomes were found, but higher costs were incurred by
the intervention group.
In contrast to studies identified in the UK, several US stud-
ies reported quite favourable results for ECD programmes.
Most of these studies do not report outcomes for mental
well-being per se, but they have been included in the anal-
ysis because they address well-accepted risk factors for
mental disorders.
In the United States Schweinhart et al. (2005) [48] evalu-
ated the monetary net benefits for pre school-support for
children with low IQs from families with low socio-eco-
nomic status. To do so he used effectiveness data from a
specific pre-school programme ('Perry Pre School Pro-
gramme'). Compared to the control-group, net benefits in
a long-term evaluation arising from better school per-
formance, higher income, reduced crime, fewer drug
problems and reduced use of anti-depressants were
shown. The results could, however be overestimated as
the intervention was described as a pilot programme
where the teachers involved were particularly committed
to the programme.
Lynch (2004) [36] also used the 'Perry Pre-School study',
together with three other studies that had similar aims, to
calculate the long-term net benefit from the perspective of
the tax payer and the public purse. According to his
results, if provided to 20% of all US three and four year
old children living in poverty, the programmes would
result in benefit-cost ratios between US$ 4.01:1 and US$
9.27:1 (€ 3.42:1 and € 7.91:1), depending on the differ-
ent programmes' effects. Furthermore, he argued that after
17 years, the net effect on the government's budget from
rolling out one of the programmes, 'Perry Preschool', on a
nationwide basis would be positive. Despite this finding,
generalising the results from a regionally developed and
implemented programme to a broader context where edu-
cational systems may differ dramatically, raises issues of
uncertainty, the more so, as this programme was devel-
oped in the 1960s and may be less appropriate to the
twenty first century.
The final study identified was a simulation study by Aos et
al. (2004) [37]. They quantified the effects found in scien-
tific literature on ECD and adolescent support pro-
grammes, made some adjustments for the quality ofBMC Public Health 2008, 8:20 http://www.biomedcentral.com/1471-2458/8/20
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effectiveness data and estimated the monetary benefits
and costs for the selected studies. The results illustrate that
from 61 selected interventions net benefits could be
shown for almost two thirds. The results range from a net
benefit of US$ 33,100 (€ 28,000) to net costs of US$
52,000 (€ 44,000). The highest net benefits were demon-
strated for juvenile offender programmes. Additionally,
evidence for net benefit was presented for some home vis-
iting programmes that were targeted at high-risk and/or
low-income mothers. Each programme area that was
examined had some interventions that were not cost effec-
tive. In addition to the limitations described for the previ-
ous examples, a further restriction of this analysis was that
studies where outcomes could not be monetised were
excluded.
Discussion
With regard to quality criteria for health economic evalu-
ations [25,34] only a few of the reviewed studies provide
strong evidence that preventive interventions are cost-
effective. The clearest evidence, albeit in a US context, sug-
gests that early intervention programmes for children and
adolescents are worth financing [36,37,48].
By contrast, despite the fact that the reduction of suicide is
often one of the few defined targets for population mental
health in many countries, there remain few studies to date
that look at the cost effectiveness of suicide prevention
programmes. In many respects this is not surprising, as
comparatively few interventions have been the subject of
effectiveness analysis [50]. This is one area where work is
clearly needed.
While the number of studies identified in this area
remains very limited, some analysis now suggests that the
potential cost effectiveness may compare very favourably
with those for other public health interventions if strate-
gies can be demonstrated to be effective in averting sui-
cides [51]. This may remain the case even if a conservative
approach to costs is adopted, focusing solely on the
immediate direct costs of suicide and future lost produc-
tivity costs averted, rather than also including the intangi-
ble costs to individuals of the immediate and unexpected
loss of life that account for as much as 70% of the costs of
suicide in some studies [52].
Challenges in generating and assessing effectiveness
The variability in the quality of all studies identified is
marked, although given the extra challenges, the majority
of evaluators tried to develop appropriate, pragmatic and
creative study designs. As with other areas of public health
evaluation, the principal challenges do not relate to eco-
nomic evaluation per se, but rather to the generation and
attribution of effectiveness data for complex interventions
with long-term outcomes.
Although the knowledge about risk factors for mental dis-
orders has grown rapidly [5,11-15,53,54], there is no sin-
gle risk factor which can explain more than 15% of the
onset of a mental disorder [15]. Consequently, the detec-
tion of statistically significant risk reduction in poor men-
tal health by an intervention may require very large
sample sizes; something that is not practical or financially
feasible in most studies. Effectiveness may, however be
increasingly detected in interventions that are directed at
several risk factors in high risk populations [55]. A similar
problem arises with suicides. Completed suicides are in
absolute terms relatively rare events in most countries,
making it difficult to demonstrate the impact of interven-
tion on suicides at national level, let alone at a sub
national level.
Moreover, as with many other public health interven-
tions, the long time frame between intervention and effect
is a major barrier to assessing the long term effectiveness
of interventions, although judicious use of modelling may
help at least to look at potential cost effectiveness of inter-
ventions if different levels of effect are achieved. Nonethe-
less, greater investment in long-term follow up studies is
required to overcome this problem.
Despite this limitation, there is an evidence base indicat-
ing that many severe mental disorders which appear in
late adolescence or early adulthood may be associated
with risk factors that manifest themselves in early child-
hood [e.g. [13,56,57]]. While long term 'Framingham
studies' in mental health remain rare, there are several
studies that have monitored the health and socio-eco-
nomic circumstances of cohorts of children over several
decades in countries including England [7], New Zealand
[10] and the United States [8]. These are now being used
to illustrate that the absence of intervention in childhood
for mental health problems may have long standing and
profound socio-economic consequences in adulthood.
While these studies remain relatively rare, and moreover
were not intended originally to identify mental health
problems in childhood, they can be helpful in a policy
context. Opportunities for more prospective evaluation
may now arise [58].
Generalisability of findings
Another challenge, given the limited number of studies
available, is the extent to which the results from the eval-
uations may be of use in other countries or even in differ-
ent regions within the same country. Due to the specific
programme context of many interventions, the scope for
generalisability and transferability may be restricted. The
effectiveness of two identical mental health promotion or
prevention programmes may vary considerably depend-
ing on the context and setting where the intervention is
implemented. This is related to the cultural, social andBMC Public Health 2008, 8:20 http://www.biomedcentral.com/1471-2458/8/20
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economic context of the study population which can have
a significant influence on the intervention process and its
effect. As has been shown earlier, examples include those
home-visiting programmes targeted at low-income moth-
ers which have shown favourable results in the US but
failed to show benefits in the UK. This also indicates the
importance of gathering qualitative data on the process by
which interventions are delivered which should help
understand what factors lead individuals to make use of
health promoting interventions. Ideally this could be
undertaken concurrently with economic evaluation and
may also help policy makers elsewhere both identify and
estimate the costs of adaptations required to implement
interventions in their own jurisdictions.
Limitations of the review
The small number of studies identified as part of this
review may, to some degree, be an artefact of the difficulty
in conducting a review of economic evaluations in the
areas of health promotion and public health. This has
been highlighted previously [59,60]. Designing a search
strategy that has a high degree of precision, that is it will
find a high proportion of relevant studies, is difficult to
achieve without making use of a wide range of terms
related to public health and health promotion. The
number of irrelevant papers in the total recall rate, that is
the total number of studies identified, in our study was
high, although in absolute terms the 398 studies initially
identified is a modest number compared to many reviews
in more medical areas. This low number of studies might
also reflect the misclassification of economic terms in
databases, which may mean that bone fide economic eval-
uations are overlooked [61].
Our exclusion criteria and review protocol also would
have excluded studies which address mental health as part
of general health promoting strategies, but do not distin-
guish between mental and physical health. Examples for
this are the numerous workplace health promotion pro-
grammes that do not address mental health directly but
still may have a positive impact on mental health. In addi-
tion, our reliance on the use of abstracts to determine
whether or not to include or exclude studies might also
mean that relevant studies might have been inadvertently
excluded. Despite these limitations, our lack of economic
workplace mental health promotion studies for instance,
is consistent with other reviews in this area, which have
reported few specific mental health orientated pro-
grammes, although stress reduction programmes are
increasingly forming an element of workplace health pro-
motion programmes [62].
Conclusion
MHP and MDP interventions have a high potential to be
of economic benefit to society. The evidence base at
present is scant, making it difficult to formulate general
recommendations on how to prioritise between individ-
ual interventions. Moreover, information to aid in the
transferability of available results to different contexts and
settings is limited. More country and population specific
economic evaluations are required to strengthen this evi-
dence base. Some of this, inevitably will mean commis-
sioning new studies, which may take some time to deliver
results; those who fund effectiveness evaluations might be
encouraged to include economic analysis in their terms of
reference for prospective applicants.
In the short term, another way of developing the evidence
base, would be to retrospectively conduct economic eval-
uations making use of existing effectiveness data and
attaching local estimates of resource use and costs to these
interventions. This practice is common in other areas of
economic evaluation, and some initiatives have been
started to apply it in the area of MHP and MDP. Again,
despite all their limitations, careful use of economic mod-
els might also help to provide some indication of the
potential long term impact and economic consequences
of interventions.
It will also be important when looking, not just at MHP or
MDP, but all areas of health promotion and public health,
that innovative evaluation designs are used. Conventional
health economic evaluation does not typically consider
issues governing the uptake and appropriateness of inter-
ventions to different populations. It is important to build
into evaluation an assessment of the costs and resources
required to implement interventions in different settings,
cultures and contexts, and to obtain qualitative informa-
tion on the success and obstacles to implementation. This
type of analysis does not typically fall within the prove-
nance of health economists and emphasises the need for
a multi-disciplinary approach to evaluation. Much work
remains to be done in order to gain more evidence as well
as to foster methodological development.
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Appendix: Excluded references after full-text 
retrieval
No full economic evaluation (n = 10):
1. Wolfersdorf M, Martinez C: Suizid bei Depression.
Verlorene Lebensjahre und Bruttosozialprodukt. Was
bringt die Suizidprävention? Psychiatrische Praxis 1998,
25:139–141.
2. Oberender P, Zerthh J: Suizid und Gesundheitsökono-
mie: Rentiert sich eine Suizidprävention? In Suizidforsc-
hung und Suizidprävention am Ende des 20 Jhdts. Edited by
Wolfersdorf M, Franke C. Regensburg: Roderer; 2000
3. Smith JL, Rost K, Nutting PA, Libby AM, Elliott CE, Pyne
JM: Impact of Primary Care Depression Intervention on
Employment and Workplace Conflict Outcomes: Is
Value Added? The Journal of Mental Health Policy and Eco-
nomics 2002, 5:43–49.
4. Chatterji P, Caffray C, Crowe M, Freeman L, Jensen P:
Cost Assessment of a School-Based Mental Health
Screening and Treatment Program in New York City.
Mental Health Services Research 2004, 6:155–166.
5. Knapp M, Barrett B, Byford S, Hallam A, Davis H, Tsian-
tis J, Puura K, Ispanovic-Radojkovic V, Paradisiotou A: Pri-
mary Prevention of Child Mental Health Problems
using Primary Health Care Professionals. Cost Compar-
isons.  International Journal of Mental Health Promotion
2005, 7:95–102.
6. Pelletier KR, Lutz R: Healthy People – Healthy Busi-
ness: A Critical Review of Stress Management Programs
in the Workplace. American Journal of Health Promotion
1998, 2:5–12.
7. Smit F, Ederveen A, Cuijpers P, Deeg D, Beekman A:
Opportunities for Cost-effective Prevention of Late-Life
Depression.  Archives of General Psychiatry 2006,
63:290–296.
8. Price RH, Van Ryn M, Vinokour A: Impact of a Preven-
tive Job Search Intervention on the Likelyhood of
Depression Among the Unemployed. Journal of Health
and Social Behaviour 1992, 33:158–167.
9. Bödeker W, Kreis J: Der ökonomische Nutzen betrie-
blicher Gesundheitsförderung.  Prävention  2002,
4:106–109.
10. Warner KE, Wickizer TE, Wolfe RA, Schildroth JE, Sam-
uelson MH: Economic Implications of Workplace
Health Promotion Programs: Review of the Literature.
Journal of Occupational Medicine 1988, 30:106–112.
Prevention of alcohol dependency (n = 4):
1. Gomel M, Wutzke SE, Hardcastle DM, Lapsley H,
Reznik RB: Cost-Effectiveness of Strategies to Market
and Train Primary health Care Physicians in Brief Inter-
vention Techniques for hazardous Alcohol Use. Social
Science and Medicine 1998, 47:203–211.
2. Lindholm L: Alcohol advice in primary health care. Is
it a wise use of resources? Health Policy 1998, 45:47–56.
3. Chisholm D, Rehm J, Van Ommeren M, Monteiro M:
Reducing the Global Burden of Hazardous Alcohol Use:
A Comparative Cost-Effectiveness Analysis.  Journal of
Studies on Alcohol 2004, 65:782–793.
4. Deitz D, Cook R, Hersch R: Workplace Health Promo-
tion and Utilization of Health Services. The Journal of
Behavioural Health Services & Research 2005, 32:306–319.
Too general/no focus on MHP/MDP (n = 2):
1. Pelletier KR: A Review and Analysis of the Clinical-
and Cost-effectiveness and Disease Management Pro-
grams at the Worksite: 1998–2000 Update.  American
Journal of Health Promotion 2001, 16:107–116.
2. Pelletier KR: A Review and Analysis of the Health and
Cost-Effective Outcome Studies of Comprehensive
Health Promotion and Disease Prevention Programs.
American Journal of Health Promotion 1991, 5:311–313.
(Drug)therapy studies (n = 2):
1. Freemantle N, House A, Song F, Mason JM, Sheldon TA:
Prescribing selective serotonin reuptake inhibitors as
strategy for prevention of suicide. British Medical Journal
1994, 309:249–253.
2. Zhang M, Rost K, Fortney JC, Smith GR: A Community
Study of Depression Treatment and Employment Earn-
ings. Psychiatric Services 1999, 50:1209–1213.
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